We are live on ! Find out more
GSEP

Golden State Equity Partners Portfolio holdings

AUM $37.1M
1-Year Est. Return 20.75%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+20.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$198M
AUM Growth
-$47.5M
Cap. Flow
-$60.5M
Cap. Flow %
-30.58%
Top 10 Hldgs %
32.6%
Holding
275
New
40
Increased
54
Reduced
77
Closed
101
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSCM
151
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$228K 0.12%
10,673
-127
-1% -$2.73K
BSCO
152
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$226K 0.11%
+10,373
New +$227K
LIN icon
153
Linde
LIN
$228B
$223K 0.11%
+644
New +$209K
TRV icon
154
Travelers Companies
TRV
$80B
$223K 0.11%
1,425
-20
-1% -$3.13K
VWO icon
155
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$222K 0.11%
4,497
-697
-13% -$35.1K
AMT icon
156
American Tower
AMT
$78.8B
$220K 0.11%
753
-17
-2% -$4.64K
NOC icon
157
Northrop Grumman
NOC
$79.8B
$218K 0.11%
+564
New +$210K
ENB icon
158
Enbridge
ENB
$114B
$212K 0.11%
+5,421
New +$217K
PEP icon
159
PepsiCo
PEP
$189B
$211K 0.11%
1,212
-302
-20% -$49.3K
TXN icon
160
Texas Instruments
TXN
$255B
$205K 0.1%
1,090
-361
-25% -$69.3K
XOM icon
161
ExxonMobil
XOM
$631B
$203K 0.1%
3,325
-8,586
-72% -$537K
MCA
162
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$191K 0.1%
12,000
JBIO
163
Jade Biosciences
JBIO
$1.38B
$188K 0.1%
+455
New +$230K
CBAY
164
DELISTED
Cymabay Therapeutics
CBAY
$171K 0.09%
50,500
+17,650
+54% +$67K
BCRX icon
165
BioCryst Pharmaceuticals
BCRX
$2.4B
$158K 0.08%
+11,435
New +$151K
CNTA
166
DELISTED
Centessa Pharmaceuticals
CNTA
$156K 0.08%
+13,870
New +$187K
TLIS
167
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$89K 0.05%
+1,476
New +$110K
CLSD
168
DELISTED
Clearside Biomedical
CLSD
$84K 0.04%
+2,035
New +$132K
AUTL
169
Autolus Therapeutics
AUTL
$538M
$55K 0.03%
+10,505
New +$63K
CKPT
170
DELISTED
Checkpoint Therapeutics
CKPT
$41K 0.02%
+1,310
New +$43.4K
CYPH
171
Cypherpunk Technologies Inc
CYPH
$74.2M
$38K 0.02%
+1,165
New +$32.3K
BNGO icon
172
Bionano Genomics
BNGO
$12.6M
$36K 0.02%
+20
New +$53.5K
MREO
173
Mereo BioPharma
MREO
$48.7M
$32K 0.02%
+20,300
New +$40.6K
ORTX
174
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$28K 0.01%
+2,145
New +$35.5K
AAP icon
175
Advance Auto Parts
AAP
$3.56B
-1,489
Closed -$311K

Similar funds

Golden State Equity Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Golden State Equity Partners held 275 positions worth $198M, down 19% from $245M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Golden State Equity Partners withdrew a net $60.5M in Q4 2021, closing 101 positions and reducing 77 holdings. Its most notable exit was Arbor Realty Trust, an estimated $1.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Golden State Equity Partners opened a new position in AT&T worth $1.24M.

  • Golden State Equity Partners's largest Q4 2021 buy was AT&T: 66,816 shares worth $1.24M.
  • Golden State Equity Partners added most to WisdomTree Yield Enhanced US Aggregate Bond Fund in Q4 2021, an estimated $3.59M increase.
  • Golden State Equity Partners's biggest Q4 2021 reduction was First Trust Mid Cap Core AlphaDEX Fund, cutting an estimated $6.62M.
  • Golden State Equity Partners fully exited Arbor Realty Trust in Q4 2021, selling an estimated $1.87M.
  • Golden State Equity Partners's ten largest holdings make up 33% of its $198M portfolio in Q4 2021.
  • Golden State Equity Partners opened 40 new positions and closed 101 in Q4 2021.
  • Golden State Equity Partners's portfolio value fell 19% quarter-over-quarter to $198M.

Based on Golden State Equity Partners's 13F filing for Q4 2021, filed 11 Feb 2022.